British Pharmacopoeia Commission

The British Pharmacopoeia Commission is appointed by the Health and Agriculture Ministers, that is to say in respect of England, Scotland and Wales the Secretary of State concerned with health in England and the Secretary of State concerned with the Environment, Food and Rural Affairs and in respect of Northern Ireland the Minister of Health, Social Services and Public Safety and the Minister of Agriculture and Rural Development, acting jointly, in exercise of their powers under section 4 of the Medicines Act 1968.
The duties of the British Pharmacopoeia Commission are as follows:
(a) the preparation under section 99(1) of the Act of any new edition of the British Pharmacopoeia;
(b) the preparation under section 99(1) of the Act, as given effect by section 102(1) thereof, of any amendments of the edition of the British Pharmacopoeia published in 1968 or any new edition of it;
(c) the preparation under section 100 of the Act (which provides for the preparation and publication of lists of names to be used as headings to monographs in the British Pharmacopoeia) of any list of names and the preparation under that section as given effect by section 102(3) of the Act of any amendments of any published list;
(d) the preparation under section 99(3)(b) of the Act of any compendium or any new edition thereof;
(e) the preparation under section 99(3)(b) of the Act, as given effect by section 102(1) thereof, of any amendments to any such compendium.
Members of the British Pharmacopoeia Commission are appointed by Ministers, having regard to recommendations made by the Medicines Commission. Appointments are usually for a (renewable) term of 4 years.
Membership of the British Pharmacopoeia Commission. The list below includes those members who served during the period 2002 to 2003.
Chairman
Professor Derek H Calam OBE MA DPhil CChem FRSC FRSA HonMRPharmS HonMBIRA
Visiting Professor of Pharmaceutical Sciences, University of Strathclyde; formerly European Co-ordinator, National Institute for Biological Standards and Control
Vice-Chairman
Professor John A Goldsmith BSc PhD CChem FRSC FIQA
Visiting Professor, University of Strathclyde; formerly a Director of Technical Operations, Roche
Dr Anthony H Andrews BVetMed PhD MRCVS
Veterinary Consultant
Professor Graham Buckton BPharm PhD DSc AKC FRPharmS CChem FRSC
Professor of Pharmaceutics; School of Pharmacy, University of London
Mrs Margaret A Dow MSc MRPharmS
Consultant in the regulation of biological and biotechnological products
Dr Thomas D Duffy BSc PhD FRPharmS CChem MRSC FIQA MRQA
Consultant in quality management systems, quality assurance and training in production, development and QC Laboratories; formerly Head of the Medicines Testing Laboratory
Mr V'Iain Fenton-May BPharm MI PharmM FRPharmS
Specialist Quality Controller to the Welsh Hospitals
Dr Rodney L Horder BPharm PhD MRPharmS
Vice President, Global Pharmaceutical R & D Quality Assurance, Abbott Laboratories
Dr Aileen M T Lee BVMS PhD MRCVS
Member of the Veterinary Medicines Directorate
Specialism: Regulation of Veterinary Immunological Products
Professor John M Midgley OBE BSc MSc PhD FRPharmS CChem FRSC
Emeritus Professor of Pharmaceutical and Medicinal Chemistry, University of Strathclyde
Professor Anthony C Moffat BPharm PhD DSc CChem FRSC FRPharmS FCPP
Chief Scientist, Royal Pharmaceutical Society of Great Britain; Royal Pharmaceutical Society Professor, School of Pharmacy, University of London
Professor John O'Grady MD FRCP FFPM FBIRA
Medical Director for Europe, Daiichi Pharmaceutical Company
Dr Norman Randall PhD CChem FRSC FIQA
Consultant in Quality Assurance; formerly a Director of Quality Assurance, Aventis
Dr Gareth D Rees BPharm PhD MRPharmS CChem MRSC FIQA
A Director of Quality Assurance, Wyeth Europa
Professor David Woolfson BSc PhD CChem FRSC MPSNI
Professor of Pharmaceutics, Queens University of Belfast
Secretary and Scientific Director
Dr Gerard Lee BPharm PhD FRPharmS MRSC CChem
Membership of Committees and Consultative GroupsThe Commission appointed the following Committees and Corresponding Consultative Groups to advise it in carrying out its duties. Membership has changed from time to time; the lists below include all who have served during the period 2002 to 2003.